$2.06
0.24% today
Nasdaq, Aug 12, 04:22 pm CET
ISIN
KYG108301006
Symbol
BYSI

BeyondSpring Inc. Stock price

$2.05
-0.26 11.26% 1M
+0.39 23.49% 6M
+0.42 25.77% YTD
+0.18 9.63% 1Y
+0.53 34.87% 3Y
-9.00 81.45% 5Y
-14.75 87.80% 10Y
-14.75 87.80% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.05 2.50%
ISIN
KYG108301006
Symbol
BYSI
Industry

Key metrics

Basic
Market capitalization
$82.7m
Enterprise Value
$74.1m
Net debt
positive
Cash
$8.5m
Shares outstanding
40.3m
Valuation (TTM | estimate)
P/E
negative | -
P/S
82.6 | -
EV/Sales
74.1 | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-95.9%
Return on Equity
33.8%
ROCE
-76.9%
ROIC
-110.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.0m | -
EBITDA
$-18.7m | -
EBIT
$-18.8m | -
Net Income
$-13.9m | -
Free Cash Flow
$-4.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
-1,870.6% | -
EBIT
-1,878.6%
Net
-1,390.8% | -
Free Cash Flow
-424.8%
More
EPS
$-0.3
FCF per Share
$-0.1
Short interest
7.5%
Employees
40
Rev per Employee
$0.0
Show more

Is BeyondSpring Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

BeyondSpring Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a BeyondSpring Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a BeyondSpring Inc. forecast:

Buy
86%
Hold
14%

Financial data from BeyondSpring Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1 1
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 12 12
-
1,212%
- Research and Development Expense 7.67 7.67
-
767%
-19 -19
-
-1,871%
- Depreciation and Amortization 0.08 0.08
-
8%
EBIT (Operating Income) EBIT -19 -19
-
-1,879%
Net Profit -14 -14
-
-1,391%

In millions USD.

Don't miss a Thing! We will send you all news about BeyondSpring Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BeyondSpring Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
FLORHAM PARK, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) today announced publication of a human clinical study in Med (Cell Press) demonstrating that Plinabulin, when combined with radiation and a checkpoint inhibitor, induces dendritic cell (DC) maturation and elicits tumor responses in patients across multiple cancer types who had failed prior ICI therapy. The st...
Neutral
GlobeNewsWire
2 months ago
FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it presented interim phase 2 data on the 303 Study, a study in 2L/3L non-small cell lung cancer (NSCLC) after disease progression on 1L PD-1/L1 inhibitors with and ...
Neutral
GlobeNewsWire
3 months ago
FLORHAM PARK, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical‑stage global biopharmaceutical company focused on developing cancer therapeutics, today announced its unaudited financial results for the quarter ended March 31, 2025, and provided a corporate update.
More BeyondSpring Inc. News

Company Profile

BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Lan Huang
Employees 40
Founded 2010
Website www.beyondspringpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today